1207 - EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL).

Saved in:
Bibliographic Details
Title: 1207 - EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL).
Authors: Ascierto, P., Bastholt, L., Mohr, P., Hoeller, C., Robert, C., Larkin, J., Dummer, R., Ekbom, A., Chiarion-Sileni, V., Dutriaux, C., Mortier, L., Neyns, B., Nyakas, M., Garbe, C., Baurain, J.F., Kruse, V., Svane, I.M., Alfaya, L., Ciria, C., Blank, C.
Source: European Journal of Cancer. Feb2017 Supplement 1, Vol. 72, pS128-S128. 1p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/S0959-8049(17)30499-9